Gilead Sciences Invests in Research for COVID-19 Treatments for All Ages

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

Children are being hospitalized with COVID 19 at increasingly high rates, and those younger than 5 aren't eligible to receive a vaccine. We’re committed to helping in this area by investing in research for COVID-19 treatments for all ages.

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences.

Tweet me: .@GileadSciences is committed to helping children being hospitalized with #COVID19 by investing in research for COVID-19 treatments for all ages. #CROI2022 https://bit.ly/3GNxutP

KEYWORDS: NASDAQ: GILD, COVID-19, CROI2022

Chart showing increase in COVID-19 hospitalizations among children in the US

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.08
-2.88 (-1.39%)
AAPL  275.50
+1.82 (0.67%)
AMD  213.58
+0.01 (0.00%)
BAC  53.85
-1.54 (-2.78%)
GOOG  311.33
-7.30 (-2.29%)
META  668.69
-2.03 (-0.30%)
MSFT  404.37
-8.90 (-2.15%)
NVDA  190.05
+1.51 (0.80%)
ORCL  157.16
-2.73 (-1.71%)
TSLA  428.27
+3.06 (0.72%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.